Marshall Wace, LLP Enfusion, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.54 - $11.22 $915,672 - $1.36 Million	-121,442 Reduced 78.02%	34,221 $383,000
Q1 2023 May 15, 2023	BUY	$10.07 - $12.1 $1.14 Million - $1.37 Million	113,153 Added 266.18%	155,663 $1.63 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $14.17 $139,458 - $226,620	15,993 Added 60.31%	42,510 $411,000
Q3 2022 Nov 14, 2022	BUY	$9.66 - $15.13 $256,154 - $401,202	26,517 New	26,517 $327,000
Q1 2022 May 16, 2022	SELL	$11.96 - $21.35 $439,685 - $784,890	-36,763 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.8 - $22.94 $654,381 - $843,343	36,763 New	36,763 $769,000

117

90.9M

45K

600

Ticker ENFN
Exchange NYSE
Sector Technology
Industry Software—Application
Shares Outstandng 67,001,700
Market Cap $702M
Description
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.